← Leaderboards
Jieya Shao
Washington University
$4,238,034
Attributed
$5,186,795
Total exposure
3
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1M · FY2017–25$2M$1.5M$1M$500K$0
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$5,186,795 · 3
By mechanism
R01$4,787,222 · 2
R21$399,573 · 1
Top collaborators
- Ying Liu4 shared
Most similar at Washington University
Same institution · by research overlap
- Helen M Piwnica-Worms$9,529,923
- Ying Liu$2,843,142
- Daisy W Leung$10,142,916
- Kristen L Kroll$11,063,709
- Dineo Khabele$4,937,606
Others in their field
Other Emerging Leaders on “Chromatin”
- Michael-Christopher Keogh · Epicypher, Inc.$20,044,322
- Yin Shen · University Of California, San Francisco$11,885,334
- Carl Wu · Johns Hopkins University$11,432,082
- Jason Daniel Buenrostro · Broad Institute, Inc.$11,135,248
- Bryan J Venters · Epicypher, Inc.$10,320,127
- Ansuman Satpathy · Stanford University$10,298,673
Research focus
ChromatinNuclearProteinsCancer CellCellsTumorPhosphorylationCell LineBreast Cancer Cell LineCell SurvivalSamplingMalignant NeoplasmsDna DamageCytoplasmMalignant Breast NeoplasmChemoresistanceChemotherapyReportingGenotoxicityBreast Cancer CellCell NucleusDna RepairGrantCancer Cell Line
Grant awards (14)
Understanding the role of DNA damage repair in racial disparities of triple-negative breast cancer outcomes$455,066
R01 · FY2025 · CA · contact PI
Role of nuclear profilin-1 in DNA replication fork stability and cancer chemotherapy response$391,278
R01 · FY2025 · CA · contact PI
Understanding the role of DNA damage repair in racial disparities of triple-negative breast cancer outcomes$468,984
R01 · FY2024 · CA · contact PI
Role of nuclear profilin-1 in DNA replication fork stability and cancer chemotherapy response$371,713
R01 · FY2024 · CA · contact PI
Understanding the role of DNA damage repair in racial disparities of triple-negative breast cancer outcomes$459,705
R01 · FY2023 · CA · contact PI
Role of nuclear profilin-1 in DNA replication fork stability and cancer chemotherapy response$392,954
R01 · FY2023 · CA · contact PI
pSer784-VCP: a clinically relevant link between autophagy and DNA damage response$178,679
R21 · FY2023 · CA · contact PI
Understanding the role of DNA damage repair in racial disparities of triple-negative breast cancer outcomes$513,768
R01 · FY2022 · CA · contact PI
pSer784-VCP: a clinically relevant link between autophagy and DNA damage response$220,894
R21 · FY2022 · CA · contact PI
Understanding Spatially Regulated Tumor-Inhibitory Function of Profilin-1 and its Deregulation in Breast Cancer$348,844
R01 · FY2021 · CA · contact PI
Understanding Spatially Regulated Tumor-Inhibitory Function of Profilin-1 and its Deregulation in Breast Cancer$348,844
R01 · FY2020 · CA · contact PI
Understanding Spatially Regulated Tumor-Inhibitory Function of Profilin-1 and its Deregulation in Breast Cancer$338,378
R01 · FY2019 · CA · contact PI
Understanding Spatially Regulated Tumor-Inhibitory Function of Profilin-1 and its Deregulation in Breast Cancer$348,844
R01 · FY2018 · CA · contact PI
Understanding Spatially Regulated Tumor-Inhibitory Function of Profilin-1 and its Deregulation in Breast Cancer$348,844
R01 · FY2017 · CA · contact PI